COSA 2013* A Single Institution's Experience in Rectal Cancer (#301)
3:00 PM
Pancreatic Cancer Quality Care - Is there Consensus Amongst Clinicians? (#303)
3:00 PM
Exercise as medicine in the management of pancreatic cancer: a case study (#305)
3:00 PM
An Estimation of the Population Survival Benefit of First-line Chemotherapy for Upper Gastrointestinal Cancer (#306)
3:00 PM
Identifying Shortcomings and Variation in the Diagnosis of Colorectal Cancer Patients (#307)
3:00 PM
Retrospective analysis of resected gastrointestinal stromal tumours (GISTs) comparing existing risk stratification models and assessing the influence of GIST genotypes on recurrence and mortality (#308)
3:00 PM
A Clinical Audit of Anal Cancer in a Single Tertiary Centre Over 10 Years (#309)
3:00 PM
Cetuximab use in metastatic colorectal cancer at Princess Alexandra Hospital: streamlined analysis using electronic medical record data (#310)
3:00 PM
Disseminated Tumour Cells (Dtcs) in Bone Marrow (BM) of Gastric Cancer Patients with M0 Category: Correlation with Tumour Hypoxia and Clinical Relevance (#311)
3:00 PM
Is Second Line Chemotherapy in Pancreatic Cancer One Line Too Many? (#312)
3:00 PM
“Life Changing” The Lived Experience of Risk Reducing Gastrectomy in People at Risk of Hereditary Diffuse Gastric Cancer. (#313)
3:00 PM